✦ LIBER ✦

Review article: current antiviral therapy of chronic hepatitis B

✍ Scribed by W. S. Ayoub; E. B. Keeffe

Book ID: 108606486
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 233 KB
Volume: 34
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2011.04869.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Review article: current antiviral therap

Review article: current antiviral therapy of chronic hepatitis B

✍ W. S. AYOUB; E. B. KEEFFE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Current Antiviral Therapy of Chronic Hep

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety

✍ Yuk-Fai Lam; Man-Fung Yuen; Wai-Kay Seto; Ching-Lung Lai 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 176 KB

Review article: chronic hepatitis B – an

Review article: chronic hepatitis B – anti-viral or immunomodulatory therapy?

✍ V. Rijckborst; M. J. Sonneveld; H. L. A. Janssen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Treatment of chronic hepatitis B: New an

Treatment of chronic hepatitis B: New antiviral therapies

✍ Francis Yao; Robert G. Gish 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 325 KB

Adherence to antiviral therapy in chroni

Adherence to antiviral therapy in chronic hepatitis C

✍ Keyur Patel; Anouk T. Dev 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 353 KB

Serum HBeAg quantitation during antivira

Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B

✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of